Impaired lysosomal biogenesis and acidification, which has been observed in the brains of AD patients, can lead to insufficient clearance of Aβ peptides and tau protein, two major hallmarks of AD [6, 7]. The gene discussed is MAPT; the disease is Alzheimer disease.